Market News & Trends
Vifor Pharma & ChemoCentryx Announce Expansion of Avacopan Agreement
Vifor Pharma and ChemoCentryx, Inc. recently announced that Vifor Pharma has gained rights to commercialize avacopan in Asia, including Japan and the Middle-East. ChemoCentryx retains…
REGENXBIO Announces IND Active for Phase I Trial
REGENXBIO Inc. recently announced the Investigational New Drug application (IND) is active for the planned multi-center, open-label, multiple-cohort, dose-escalation Phase I clinical trial of RGX-314…
NexImmune Acquired by a Consortium of Private Investors Led by Former Celgene & Medtronic CEOs
NexImmune, a biopharmaceutical company developing novel immunotherapeutics based on the Artificial Immune (AIM) nanotechnology platform, recently announced the completion of the acquisition of the company…
Roche to Gain Most as Biogen Remains Leader in Neurodegenerative Drugs Market
Roche will be the biggest mover in the neurodegenerative drugs space throughout the next 5 years, with the anticipated approval of ocrelizumab driving the company’s…
Catalent Completes Accucaps Acquisition to Expand Softgel Development Manufacturing Capabilities & Capacity
Catalent, Inc. recently announced it has completed the acquisition of Accucaps Industries Limited (Accucaps), the Canada-based developer and manufacturer of OTC, high-potency, and conventional pharmaceutical…
Ascendia Pharmaceuticals Announces Issuance of New Patent for Acute Coronary Syndrome Program
Ascendia Pharmaceuticals, a specialty pharmaceutical company engaged in nano-formulation design, development, and manufacture for poorly soluble molecules, recently announced it has been awarded a new…
Ascendia Pharmaceuticals Announces Issuance of New Patent for Acute Coronary Syndrome Program
Ascendia Pharmaceuticals, a specialty pharmaceutical company engaged in nano-formulation design, development, and manufacture for poorly soluble molecules, recently announced it has been awarded a new…
Pfizer CentreOne Expands Fill-Finish Services
Pfizer CentreOne, a global contract manufacturing organization embedded within Pfizer, recently announced that it has expanded its fill-finish services to its Kalamazoo, MI, site. Along…
Pfizer CentreOne Expands Fill-Finish Services
Pfizer CentreOne, a global contract manufacturing organization embedded within Pfizer, recently announced that it has expanded its fill-finish services to its Kalamazoo, MI, site. Along…
Q BioMed, Oklahoma Medical Research & Rajiv Gandhi Centre to Develop Chemotherapeutic Technology
Q BioMed, Inc. has entered into an agreement with the Oklahoma Medical Research Foundation (OMRF) and the Rajiv Gandhi Centre for Biotechnology (RGCB) to develop…
Lupus R&D Landscape Set to be Dominated by Big Pharma & Small Biotech Partnerships
The lupus market, which is set to reach $3.2 billion by 2025 and has historically been dominated by inexpensive generic drugs, will see a future…
Metrics Contract Services: Your "Concept to Commercialization" Partner
The parent company of Metrics Contract Services, Mayne Pharma, is investing $80 million to significantly expand facilities and equipment at its site in Greenville, N.C.…
MedCrypt & QuiO Partner on Device Security for Safe Transfer of Prescriptions & Injection Data
MedCrypt, an early stage medical device software security company, and QuiO, an early stage connected therapeutics company, recently announced an integration partnership for the Smartinjector…
GW Pharmaceuticals Achieves Positive Results in Phase II Study
GW Pharmaceuticals plc recently announced positive top-line results from an exploratory Phase II placebo-controlled clinical study of a proprietary combination of tetrahydrocannabinol (THC) and cannabidiol…
Galectin Presents Clinical Data of Combination Immunotherapy With Galectin-3 Inhibitor GR-MD-02
Galectin Therapeutics Inc. and the Providence Cancer Center recently announced the presentation of preclinical and early clinical data from two investigator-initiated Phase I clinical trials…
Metrics Contract Services: Your "Concept to Commercialization" Partner
The parent company of Metrics Contract Services, Mayne Pharma, is investing $80 million to significantly expand facilities and equipment at its site in Greenville, N.C.…
Foster Delivery Science & ProMed Pharma Partner
Foster Delivery Science and ProMed Pharma have entered into a commercial partnership to provide comprehensive contract services for pharmaceutical and combination device applications. Jointly, the…
Pharma & Biotech: 2017 Review of Outsourced Manufacturing
Foreword I am pleased to introduce you to our 2017 review of the outsourced manufacturing sector, where we share some of the trends…
Foster Delivery Science & ProMed Pharma Partner
Foster Delivery Science and ProMed Pharma have entered into a commercial partnership to provide comprehensive contract services for pharmaceutical and combination device applications. Jointly, the…
Pharma & Biotech: 2017 Review of Outsourced Manufacturing
Foreword I am pleased to introduce you to our 2017 review of the outsourced manufacturing sector, where we share some of the trends…
